CSIMarket
 
Plus Therapeutics Inc   (NASDAQ: PSTV)
 

Plus Therapeutics Inc's Suppliers Performance

PSTV's Supply Chain




 
PSTV Costs vs Sales of Suppliers Growth

• More on PSTV Suppliers






Plus Therapeutics Inc's Comment on Supply Chain


The company utilizes third-party manufacturers to produce, supply, store, and distribute product candidates for clinical trials and potential commercial use. It does not currently plan to develop internal manufacturing capacity and lacks long-term supply agreements with contract manufacturing organizations (CMOs). Risks associated with this reliance include limited manufacturer availability, potential failure to meet volume and quality standards, possible non-performance or business exit by manufacturers, the need for additional studies if CMOs change, regulatory compliance challenges, intellectual property sharing concerns, and the risk of knowledge transfer to competitors. These factors may delay clinical trials, regulatory approvals, and commercialization, potentially increasing costs and reducing revenues.

Plus Therapeutics Inc's Comment on Supply Chain


The company utilizes third-party manufacturers to produce, supply, store, and distribute product candidates for clinical trials and potential commercial use. It does not currently plan to develop internal manufacturing capacity and lacks long-term supply agreements with contract manufacturing organizations (CMOs). Risks associated with this reliance include limited manufacturer availability, potential failure to meet volume and quality standards, possible non-performance or business exit by manufacturers, the need for additional studies if CMOs change, regulatory compliance challenges, intellectual property sharing concerns, and the risk of knowledge transfer to competitors. These factors may delay clinical trials, regulatory approvals, and commercialization, potentially increasing costs and reducing revenues.







PSTV's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Plus Therapeutics Inc 26.48 4.20 -26.09 28
SUBTOTAL 0.00 0.00 0.00 -


Sources: Plus Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Plus Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.